This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Therapeutic Nuclear Medicines Market

Market Insights on Therapeutic Nuclear Medicines covering sales outlook, demand forecast & up-to-date key trends

Therapeutic Nuclear Medicines Market By Treatment (Radium-223, Iodine-131, Leutitium-177, Yttrium-90, Samarium-153, Strontium-89, Rhenium-188+Rhenium-186, Erbium- 169, Phosphorous-32), Indication (Prostate Cancer, Painful Bone Metastases, Thyroid Cancer, Neuroblastoma, Synovitis, Non-Hodgkin's Lymphoma, Hepatic Metastases, Brain Tumour) & Region - Forecast 2022 - 2028

Therapeutic Nuclear Medicines Market Outlook (2022-2028)

[237 Pages Report] Expanding at a CAGR of 10.6%, the global therapeutic nuclear medicines market is projected to increase from a valuation of US$ 1 Bn in 2022 to US$ 1.84 Bn by 2028.

Therapeutic Nuclear Medicines Market Size (2022)

US$ 1 Bn

Sales Forecast (2028)

US$ 1.84 Bn

Global Market Growth Rate (2022 to 2028)

10.6% CAGR

Share of Top 5 Market Players

60%

Therapeutic nuclear medicine consumption accounted for 18.1% share of the global nuclear medicine market in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Consumption Analysis of Therapeutic Nuclear Medicines (2013-2021) Vs Market Outlook (2022 to 2028)

“Growing Need for Early & Reliable Diagnosis – Need of the Hour”

From 2013 to 2021, the global therapeutic nuclear medicines market registered significant gains, experiencing a CAGR of 9.2%

A pharmaceutical composition including radioactive elements is known as therapeutic nuclear medicine. In comparison to X-rays and other external radiation imaging technologies, therapeutic nuclear medicines are widely employed as an effective and safer alternative for cancer patients. Chemotherapy is being mainly supplanted by nuclear medications for cancer treatment as a result of this.

Therapeutic Nuclear Medicines Market Download Report Brochure

Nuclear medicine is widely utilized for the early diagnosis and treatment of a variety of chronic disorders. Nuclear medicine is consumed, injected, or inhaled, depending on the technique. These drugs are becoming increasingly important for delivering imaging and data on biochemical changes, which was previously difficult to access.

To reproduce internal images, these drugs move through the body as gamma rays, which must be intercepted by computers and sophisticated cameras. The therapeutic nuclear medicines industry is predicted to grow due to an increase in chronic diseases and increased knowledge of nuclear medicine.

Considering these factors, the market is projected to witness high growth over the forecast period, registering a CAGR of 10.6% to reach US$ 1.84 Bn by 2028.

What are the Main Drivers of the Therapeutic Nuclear Medicines Market?

“Increasing Acceptance of Radiopharmaceuticals for Therapeutic Purposes”

The therapeutic nuclear medicines industry is growing owing to the incidence rates of cancer and cardiac illnesses, as well as attempts to address the supply gap for Mo-99 and radiopharmaceuticals. Thyroid issues, lung ailments, bone diseases, and brain disorders like neuroblastoma are some of the conditions for which studies and research are conducted.

For oncology and cancer treatment, traditional chemotherapy techniques are being substituted by more efficient therapeutic radiopharmaceuticals that bring new paths in the radiopharmaceuticals industry. With the introduction of radiotheranostics, which integrates treatment with radioisotopes and targeted diagnosis to provide an alternative in the treatment of many cancers, the market has changed dramatically in recent years.

Radiotheranostics is focused on the use of radio-isotopes that generate radiation that can be used to specifically eliminate cancer cells. Furthermore, when compared to X-Rays and other external radiation imaging devices, it not only supports physicians in diagnosis but also serves as an efficient and secure option for patients.

In applications like lymphoma and bone metastasis, radiopharmaceuticals, also generally recognized as nuclear medicines, are used. Globally, leading pharmaceutical companies are increasingly focusing on developing important drugs that are innovative. In addition, the market for nuclear medicines is likely to play a significant part in this development.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors are Hampering Sales of Therapeutic Nuclear Medicines?

“High Cost of Nuclear Medicine Development Relative to RoI Hampering Market Growth”

Therapeutic nuclear medicines market expansion is likely to be hampered by stringent regulatory requirements and a lack of standardized resources in several developed and emerging nations. High costs, a paucity of isotopes, and the potential of conventional diagnostic testing are all impeding the demand for nuclear medicines.

Because of the radioactivity of these drugs, they can only be used in certain circumstances, such as pregnancy and in modest doses. Radiation and chemical breakdown occurs when radioisotopes are not used within the designated shelf life, reducing radiochemical purity to an extreme amount, which can be lethal during diagnostic and therapy.

Why is North America Expected to Lead the Global Therapeutic Nuclear Medicines Market?

“Growing Adoption of Nuclear Medicine Procedures as Better Medical Solutions”

Substantial market growth in North America can be linked to the development of nuclear medicine procedures, government support, increased R&D expenditure, and industry activities.

Due to supply stabilization and rising instances of chronic diseases such as cancers, the market in North America is predicted to rise rapidly. In addition, pharmaceutical industry development is on the rise.

Growing innovation, as well as faster and simpler FDA approvals, are projected to propel the therapeutic nuclear pharmaceuticals industry forward.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

What is the Outlook for the U.S. Therapeutic Nuclear Medicines Market?

“Rising Incidence of Prostate Cancer Fueling Consumption of Diagnostic Nuclear Medicines”

Prevalence of prostate cancer is rising throughout the globe, especially in the U.S. which is fueling the demand for diagnostic nuclear medicines.

According to the American Cancer Society, prostate cancer is the most common cause of death in the U.S. around 1 in 9 men are expected to be diagnosed with prostate cancer during their lifetime.

Therefore, increase in the incidence of prostate cancer is expected to drive usage of therapeutic nuclear medicines over the forecast period.

How Lucrative is the Market for Therapeutic Nuclear Medicines in China?

“Innovation in Pharmaceutical Industry Driving Demand for Therapeutic Drugs”

China is the most lucrative market for therapeutic nuclear medicines uptake, owing to the growing cancer patient pool and a continually rising rate of radiopharmaceuticals prescription in the country.

Furthermore, a number of pharmaceutical and medical businesses in China are concentrating on the development of therapeutic drugs for the diagnosis and treatment of a variety of ailments, paving the way for market growth.

Category-wise Insights

Which Treatment Accounts for Highest Revenue Generation?

“Expansion of Nuclear Imaging to Boost Demand for Samarium-153”

In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive for the treatment of various types of cancer. Samarium-153 (SM-153) is a beta-emitting drug with the extra advantage of detectable gamma emission for external imaging. The drug has been approved for use in individuals with osteoblastic metastases that can be seen on a nuclear medicine bone scan.

Several breakthroughs in Samarium-153 beta emitters would add to the segment's growth. QSAM Biosciences recently received FDA approval for Samarium-153 DOTMP, an experimental radiopharmaceutical for the treatment of bone cancer.

In addition, the launch of these products has boosted the demand for therapeutic nuclear medicines among patients and physicians as well as opened the door for other pharmaceutical manufacturers to launch more efficient therapeutic nuclear medicines.

Which Distribution Channel Will Emerge as Key Market Contributor?

“Rapid Deployment of Efficient Nuclear Medicine Therapies at Hospitals”

Hospitals are expected to account 37.3% share of the therapeutic nuclear medicines market in 2022. On the basis of the distribution channel, the global market is segmented into hospitals, ambulatory surgical centers, and cancer research institutes.

Because of the huge volume of nuclear imaging treatments performed at these institutions and the increased performance of handling these sensitive items at these sites, the hospitals segment is expected to keep a significant position.

Moreover, leading radiopharmaceutical manufacturers are collaborating with hospitals for the sale of their products, which has increased the acceptance of therapeutic nuclear medicines.

COVID-19 Impact on Therapeutic Nuclear Medicine Demand

As a result of the COVID-19 pandemic, which has resulted in lockdowns in multiple countries throughout the world, the research, production, and distribution of therapeutic nuclear medications were significantly impacted, as was the expansion of various companies' radiopharmaceutical industries.

Lockdowns led to the closure of all industrial institutions, with the exception of those that manufacture vital commodities, as well as a disruption in the supply chain for radiopharmaceuticals and diagnostic and therapeutic kits.

Recent technological developments in nuclear imaging modalities as well as the introduction of innovative pharmaceuticals into the global market have given the industry a huge boost. Continued and persistent R&D activities that result in advancements in new application areas are driving market expansion.

Competitive Landscape

Organic marketing techniques such as mergers and acquisitions, collaborations, and product launches are being used by market vendors to acquire a competitive advantage in the market. Top players produce the majority of nuclear medicine treatments products. Industry leaders have built their position in the market by investing more in research and having a better distribution system.

For instance,

  • In 2021, IBA established a strategic R&D agreement with SCK CEN to enable the manufacturing of Actinium-225, a new radioisotope. The substance is claimed to be able to help in cancer treatment.

Therapeutic Nuclear Medicines Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

Value in US$ Mn

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • U.S.
  • Canada
  • Mexico
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • Italy
  • France
  • U.K
  • Nordic
  • Spain
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • Australia
  • GCC Countries
  • South Africa
  • Turkey

Key Market Segments Covered

  • Treatment
  • Indication
  • Distribution Channel
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments of Therapeutic Nuclear Medicines Industry Survey

Therapeutic Nuclear Medicines Market by Treatment:

  • Radium-223
  • Iodine-131
  • Leutitium-177
  • Yttrium-90
  • Samarium-153
  • Strontium-89
  • Rhenium-188+Rhenium-186
  • Erbium- 169
  • Phosphorous-32
  • Others

Therapeutic Nuclear Medicines Market by Indication:

  • Prostate Cancer
  • Painful Bone Metastases
  • Thyroid Cancer
  • Neuroblastoma
  • Synovitis
  • Non-Hodgkin’s Lymphoma
  • Hepatic Metastases
  • Brain Tumour
  • Others

Therapeutic Nuclear Medicines Market by Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Therapeutic Nuclear Medicines Market by Region:

  • North America Therapeutic Nuclear Medicines Market
  • Latin America Therapeutic Nuclear Medicines Market
  • Europe Therapeutic Nuclear Medicines Market
  • East Asia Therapeutic Nuclear Medicines Market
  • South Asia & Pacific Therapeutic Nuclear Medicines Market
  • Middle East & Africa (MEA) Therapeutic Nuclear Medicines Market

Frequently Asked Questions

The global therapeutic nuclear medicines market is expected to reach US$ 1 Bn in 2022.

Increasing number of cancer cases and rising awareness about nuclear medicine are factors driving market growth.

Hospitals account for 37.3% share of the therapeutic nuclear medicines market.

Key manufacturers of therapeutic nuclear medicines are, Bayer AG, GE Healthcare, Novartis AG, Cardinal Health Inc., and Mallinckrodt plc.

The therapeutic nuclear medicines market is set to surge at a CAGR of 10.6% over the forecast period (2022-2028).

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Exclusion and Inclusion

3. Global Economic Outlook

    3.1. Gross Domestic Product by Country, 2006 - 2021

    3.2. Global Pharmaceutical Market Overview

4. Market Opportunity Analysis

    4.1. Macro-Economic Factors

    4.2. Opportunity Analysis

5. Market Dynamics

    5.1. Drivers

        5.1.1. Supply Side Drivers

        5.1.2. Demand Side Drivers

    5.2. Restraints

    5.3. Trends

6. Key Inclusion

    6.1. Parent Market Analysis

    6.2. Key Regulation

    6.3. Reimbursement Scenario

    6.4. Pipeline Assessment

    6.5. Disease Epidemiology

7. North America Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        7.2.1. U.S.

        7.2.2. Canada

    7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        7.4.1. Radium-223

        7.4.2. Iodine-131

        7.4.3. Leutitium-177

        7.4.4. Yttrium-90

        7.4.5. Samarium-153

        7.4.6. Strontium-89

        7.4.7. Rhenium-188 + Rhenium-186

        7.4.8. Erbium-169

        7.4.9. Phosphorus-32

        7.4.10. Others

    7.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        7.6.1. Prostate Cancer

        7.6.2. Painful Bone Metastases

        7.6.3. Thyroid Cancer

        7.6.4. Neuroblastoma

        7.6.5. Synovitis

        7.6.6. Non-Hodgkins Lymphoma

        7.6.7. Hepatic Metastases

        7.6.8. Brain Tumour

        7.6.9. Others

    7.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        7.8.1. Hospitals

        7.8.2. Ambulatory Surgical Centers

        7.8.3. Cancer Research Institutes

    7.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    7.10. Market Attractiveness Analysis

        7.10.1. By Radionuclide Type

        7.10.2. By Indication

        7.10.3. By End User

        7.10.4. By Country

    7.11. Drivers and Restraints: Impact Analysis

8. Latin America Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        8.2.1. Brazil

        8.2.2. Mexico

        8.2.3. Argentina

        8.2.4. Rest of Latin America

    8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    8.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        8.4.1. Radium-223

        8.4.2. Iodine-131

        8.4.3. Leutitium-177

        8.4.4. Yttrium-90

        8.4.5. Samarium-153

        8.4.6. Strontium-89

        8.4.7. Rhenium-188 + Rhenium-186

        8.4.8. Erbium-169

        8.4.9. Phosphorus-32

        8.4.10. Others

    8.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        8.6.1. Prostate Cancer

        8.6.2. Painful Bone Metastases

        8.6.3. Thyroid Cancer

        8.6.4. Neuroblastoma

        8.6.5. Synovitis

        8.6.6. Non-Hodgkins Lymphoma

        8.6.7. Hepatic Metastases

        8.6.8. Brain Tumour

        8.6.9. Others

    8.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        8.8.1. Hospitals

        8.8.2. Ambulatory Surgical Centers

        8.8.3. Cancer Research Institutes

    8.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    8.10. Market Attractiveness Analysis

        8.10.1. By Radionuclide Type

        8.10.2. By Indication

        8.10.3. By End User

        8.10.4. By Country

    8.11. Drivers and Restraints: Impact Analysis

9. Western Europe Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        9.2.1. Germany

        9.2.2. U.K

        9.2.3. France

        9.2.4. Italy

        9.2.5. Spain

        9.2.6. Rest of Western Europe

    9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        9.4.1. Radium-223

        9.4.2. Iodine-131

        9.4.3. Leutitium-177

        9.4.4. Yttrium-90

        9.4.5. Samarium-153

        9.4.6. Strontium-89

        9.4.7. Rhenium-188 + Rhenium-186

        9.4.8. Erbium-169

        9.4.9. Phosphorus-32

        9.4.10. Others

    9.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        9.6.1. Prostate Cancer

        9.6.2. Painful Bone Metastases

        9.6.3. Thyroid Cancer

        9.6.4. Neuroblastoma

        9.6.5. Synovitis

        9.6.6. Non-Hodgkins Lymphoma

        9.6.7. Hepatic Metastases

        9.6.8. Brain Tumour

        9.6.9. Others

    9.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        9.8.1. Hospitals

        9.8.2. Ambulatory Surgical Centers

        9.8.3. Cancer Research Institutes

    9.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    9.10. Market Attractiveness Analysis

        9.10.1. By Radionuclide Type

        9.10.2. By Indication

        9.10.3. By End User

        9.10.4. BY Country

    9.11. Drivers and Restraints: Impact Analysis

10. Eastern Europe Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        10.2.1. Russia

        10.2.2. Poland

        10.2.3. Rest of Eastern Europe

    10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        10.4.1. Radium-223

        10.4.2. Iodine-131

        10.4.3. Leutitium-177

        10.4.4. Yttrium-90

        10.4.5. Samarium-153

        10.4.6. Strontium-89

        10.4.7. Rhenium-188 + Rhenium-186

        10.4.8. Erbium-169

        10.4.9. Phosphorus-32

        10.4.10. Others

    10.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        10.6.1. Prostate Cancer

        10.6.2. Painful Bone Metastases

        10.6.3. Thyroid Cancer

        10.6.4. Neuroblastoma

        10.6.5. Synovitis

        10.6.6. Non-Hodgkins Lymphoma

        10.6.7. Hepatic Metastases

        10.6.8. Brain Tumour

        10.6.9. Others

    10.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        10.8.1. Hospitals

        10.8.2. Ambulatory Surgical Centers

        10.8.3. Cancer Research Institutes

    10.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    10.10. Market Attractiveness Analysis

        10.10.1. By Radionuclide Type

        10.10.2. By Indication

        10.10.3. By End User

        10.10.4. By Country

    10.11. Drivers and Restraints: Impact Analysis

11. APECJ Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        11.2.1. India

        11.2.2. Australia and New Zealand

        11.2.3. ASEAN

        11.2.4. Rest of APECJ

    11.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        11.4.1. Radium-223

        11.4.2. Iodine-131

        11.4.3. Leutitium-177

        11.4.4. Yttrium-90

        11.4.5. Samarium-153

        11.4.6. Strontium-89

        11.4.7. Rhenium-188 + Rhenium-186

        11.4.8. Erbium-169

        11.4.9. Phosphorus-32

        11.4.10. Others

    11.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        11.6.1. Prostate Cancer

        11.6.2. Painful Bone Metastases

        11.6.3. Thyroid Cancer

        11.6.4. Neuroblastoma

        11.6.5. Synovitis

        11.6.6. Non-Hodgkins Lymphoma

        11.6.7. Hepatic Metastases

        11.6.8. Brain Tumour

        11.6.9. Others

    11.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        11.8.1. Hospitals

        11.8.2. Ambulatory Surgical Centers

        11.8.3. Cancer Research Institutes

    11.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    11.10. Market Attractiveness Analysis

        11.10.1. By Radionuclide Type

        11.10.2. By Indication

        11.10.3. By End User

        11.10.4. By Country

    11.11. Drivers and Restraints: Impact Analysis

12. China Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        12.2.1. Radium-223

        12.2.2. Iodine-131

        12.2.3. Leutitium-177

        12.2.4. Yttrium-90

        12.2.5. Samarium-153

        12.2.6. Strontium-89

        12.2.7. Rhenium-188 + Rhenium-186

        12.2.8. Erbium-169

        12.2.9. Phosphorus-32

        12.2.10. Others

    12.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    12.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        12.4.1. Prostate Cancer

        12.4.2. Painful Bone Metastases

        12.4.3. Thyroid Cancer

        12.4.4. Neuroblastoma

        12.4.5. Synovitis

        12.4.6. Non-Hodgkins Lymphoma

        12.4.7. Hepatic Metastases

        12.4.8. Brain Tumour

        12.4.9. Others

    12.5. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        12.6.1. Hospitals

        12.6.2. Ambulatory Surgical Centers

        12.6.3. Cancer Research Institutes

    12.7. Market Size (US$ Mn) Forecast By End User, 2022-2028

    12.8. Market Attractiveness Analysis

        12.8.1. By Radionuclide Type

        12.8.2. By Indication

        12.8.3. By End User

    12.9. Drivers and Restraints: Impact Analysis

13. Japan Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        13.2.1. Radium-223

        13.2.2. Iodine-131

        13.2.3. Leutitium-177

        13.2.4. Yttrium-90

        13.2.5. Samarium-153

        13.2.6. Strontium-89

        13.2.7. Rhenium-188 + Rhenium-186

        13.2.8. Erbium-169

        13.2.9. Phosphorus-32

        13.2.10. Others

    13.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    13.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        13.4.1. Prostate Cancer

        13.4.2. Painful Bone Metastases

        13.4.3. Thyroid Cancer

        13.4.4. Neuroblastoma

        13.4.5. Synovitis

        13.4.6. Non-Hodgkins Lymphoma

        13.4.7. Hepatic Metastases

        13.4.8. Brain Tumour

        13.4.9. Others

    13.5. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        13.6.1. Hospitals

        13.6.2. Ambulatory Surgical Centers

        13.6.3. Cancer Research Institutes

    13.7. Market Size (US$ Mn) Forecast By End User, 2022-2028

    13.8. Market Attractiveness Analysis

        13.8.1. By Radionuclide Type

        13.8.2. By Indication

        13.8.3. By End User

    13.9. Drivers and Restraints: Impact Analysis

14. MEA Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        14.2.1. GCC Countries

        14.2.2. South Africa

        14.2.3. Rest of Middle East and Africa

    14.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    14.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021

        14.4.1. Radium-223

        14.4.2. Iodine-131

        14.4.3. Leutitium-177

        14.4.4. Yttrium-90

        14.4.5. Samarium-153

        14.4.6. Strontium-89

        14.4.7. Rhenium-188 + Rhenium-186

        14.4.8. Erbium-169

        14.4.9. Phosphorus-32

        14.4.10. Others

    14.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    14.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        14.6.1. Prostate Cancer

        14.6.2. Painful Bone Metastases

        14.6.3. Thyroid Cancer

        14.6.4. Neuroblastoma

        14.6.5. Synovitis

        14.6.6. Non-Hodgkins Lymphoma

        14.6.7. Hepatic Metastases

        14.6.8. Brain Tumour

        14.6.9. Others

    14.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    14.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        14.8.1. Hospitals

        14.8.2. Ambulatory Surgical Centers

        14.8.3. Cancer Research Institutes

    14.9. Market Size (US$ Mn) Forecast By End User, 2022-2028

    14.10. Market Attractiveness Analysis

        14.10.1. By Radionuclide Type

        14.10.2. By Indication

        14.10.3. By End User

        14.10.4. By Country

    14.11. Drivers and Restraints: Impact Analysis

15. Forecast Factors: Relevance and Impact

16. Market Structure Analysis

    16.1. Market Structure by Tier

    16.2. Market Share Analysis (2021) for Top Players, By Region

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competitors Deep Dive

        17.2.1. Bayer AG

        17.2.2. Novartis AG

        17.2.3. GE Healthcare

        17.2.4. Curium Pharmaceuticals

        17.2.5. Jubilant DraxImage

        17.2.6. Spectrum Pharmaceuticals

        17.2.7. Progenics Pharmaceuticals, Inc.

        17.2.8. ANSTO

        17.2.9. Lantheus Medical Imaging, Inc.

        17.2.10. Eckert & Ziegler

        17.2.11. International Isotopes Inc.

        17.2.12. SHINE Medical Technologies Inc.

18. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028 By Country

    18.1. Introduction / Key Findings

    18.2. Historical Market Size (US$ Mn) Analysis By Country

        18.2.1. North America

        18.2.2. Latin America

        18.2.3. Western Europe

        18.2.4. Eastern Europe

        18.2.5. Asia Pacific Excluding Japan And China

        18.2.6. China

        18.2.7. Japan

        18.2.8. Middle East and Africa

    18.3. Market Size (US$ Mn) Forecast By Country

    18.4. Market Attractiveness Analysis By Country

19. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By Radionuclide Type

    19.1. Introduction/Key Finding

    19.2. Historical Market Size (US$ Mn) Analysis By Radionuclide Type, 2013-2021

        19.2.1. Radium-223

        19.2.2. Iodine-131

        19.2.3. Leutitium-177

        19.2.4. Yttrium-90

        19.2.5. Samarium-153

        19.2.6. Strontium-89

        19.2.7. Rhenium-188 + Rhenium-186

        19.2.8. Erbium-169

        19.2.9. Phosphorus-32

        19.2.10. Others

    19.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028

    19.4. Market Attractiveness Analysis By Radionuclide Type

20. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By Indication

    20.1. Introduction/Key Finding

    20.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013-2021

        20.2.1. Prostate Cancer

        20.2.2. Painful Bone Metastases

        20.2.3. Thyroid Cancer

        20.2.4. Neuroblastoma

        20.2.5. Synovitis

        20.2.6. Non-Hodgkins Lymphoma

        20.2.7. Hepatic Metastases

        20.2.8. Brain Tumour

        20.2.9. Others

    20.3. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    20.4. Market Attractiveness Analysis By Indication

21. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By End User

    21.1. Introduction/Key Finding

    21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021

        21.2.1. Hospitals

        21.2.2. Ambulatory Surgical Centers

        21.2.3. Cancer Research Institutes

    21.3. Market Size (US$ Mn) Forecast By End User, 2022-2028

    21.4. Market Attractiveness Analysis By End User

22. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028

    22.1. Global Market Value Analysis (US$ Mn)

    22.2. Absolute $ Opportunity (US$ Mn)

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables
  1. Expenditure on Health, (% of GDP), by Country, 2016 – 2021
  2. CPT codes for Therapeutic Nuclear Medicine Procedures
  3. Estimated prevalence cases of cancer by country
  4. Clinical Trials on Therapeutic Nuclear Medicine (1/5)
  5. Clinical Trials on Therapeutic Nuclear Medicine (2/5)
  6. Clinical Trials on Therapeutic Nuclear Medicine (3/5)
  7. Clinical Trials on Therapeutic Nuclear Medicine (4/5)
  8. Clinical Trials on Therapeutic Nuclear Medicine (1/5)
  9. North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  10. North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  11. North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  12. North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  13. Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  14. Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  15. Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  16. Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  17. Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  18. Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  19. Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  20. Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  21. Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  22. Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  23. Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  24. Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  25. APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  26. APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  27. APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  28. APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  29. China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  30. China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  31. China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  32. Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  33. Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  34. Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  35. MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
  36. MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
  37. MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
  38. MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
  39. Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region
  40. Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Radionuclide Type
  41. Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Indication
  42. Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By End User
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts
  1. Global Radiopharmaceuticals Market Overview
  2. North America Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  3. North America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  4. North America Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  5. North America Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  6. North America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  7. North America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  8. U.S. Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  9. U.S. Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  10. Canada Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  11. Canada Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  12. North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  13. North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  14. North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  15. North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  16. Latin America Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  17. Latin America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  18. Latin America Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  19. Latin America Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  20. Latin America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  21. Latin America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  22. Brazil Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  23. Brazil Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  24. Mexico Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  25. Mexico Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  26. Argentina Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  27. Argentina Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  28. Rest of Latin America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  29. Rest of Latin America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  30. Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  31. Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  32. Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  33. Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  34. Western Europe Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  35. Western Europe Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  36. Western Europe Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  37. Western Europe Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  38. Western Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  39. Western Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  40. U.K. Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  41. U.K. Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  42. Germany Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  43. Germany Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  44. France Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  45. France Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  46. Italy Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn),  2013-2021
  47. Italy Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  48. Spain Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  49. Spain Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  50. Rest of Western Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  51. Rest of Western Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  52. Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  53. Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  54. Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  55. Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  56. Eastern Europe Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  57. North America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  58. Eastern Europe Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  59. Eastern Europe Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  60. Eastern Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  61. Eastern Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  62. Russia Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  63. Russia Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  64. Poland Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  65. Poland Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  66. Rest of Eastern Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  67. Rest of Eastern Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  68. Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  69. Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  70. Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  71. Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  72. APECJ Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  73. APECJ Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  74. APECJ Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  75. APECJ Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  76. APECJ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  77. APECJ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  78. India Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  79. India Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  80. Australia & NZ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  81. Australia & NZ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  82. ASEAN Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  83. ASEAN Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  84. Rest of APECJ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  85. Rest of APECJ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  86. APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  87. APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  88. APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  89. APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  90. China Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  91. China Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  92. China Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  93. China Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  94. China Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  95. China Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  96. China Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  97. China Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  98. Japan Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  99. Japan Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  100. Japan Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  101. Japan Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  102. Japan Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  103. Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  104. Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  105. Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  106. MEA Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
  107. MEA Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
  108. MEA Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
  109. MEA Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
  110. MEA Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  111. MEA Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  112. South Africa Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  113. South Africa Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  114. GCC Countries Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  115. GCC Countries Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  116. Rest of MEA Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  117. Rest of MEA Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  118. MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  119. MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  120. MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  121. MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
  122. Global Therapeutic Nuclear Medicines Market: Company Share Analysis (2021)
  123. Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Region, 2022 & 2028
  124. Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Region, 2022-2028
  125. Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Region, 2022-2028
  126. Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Radionuclide Type, 2022 & 2028
  127. Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Radionuclide Type, 2022-2028
  128. Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
  129. Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Indication, 2022 & 2028
  130. Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Indication, 2022-2028
  131. Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
  132. Global Therapeutic Nuclear Medicines Market Share Analysis (%), By End User, 2022 & 2028
  133. Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By End User, 2022-2028
  134. Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
  135. Global Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
  136. Global Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
  137. Global Therapeutic Nuclear Medicines Market Absolute $ Opportunity, 2022 - 2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Therapeutic Nuclear Medicines Market

Published : March 2022

Healthcare

Radiopharmaceuticals Market

Published : August 2021

Healthcare

Orthopaedic Imaging Equipment Market

Published : January 2022

Healthcare

Teleradiology Market

Published : March 2022

Google translate

Therapeutic Nuclear Medicines Market